Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TE
3076
T1 Energy
TE
$1.16B
| $170K | ﹤0.01% |
+100,200
| New | +$191K |
|
3077
Hanover Bancorp
HNVR
$188M
| $170K | ﹤0.01% |
+10,300
| New | +$165K |
|
|
GURE
3078
Gulf Resources
GURE
$4.65M
| $170K | ﹤0.01% |
16,499
-130
| -0.8% | -$1.89K |
|
3079
Escalade
ESCA
$273M
| $169K | ﹤0.01% |
12,230
-900
| -7% | -$12.1K |
|
|
GRIN
3080
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
| $168K | ﹤0.01% |
+12,200
| New | +$165K |
|
3081
Alset
AEI
$39.7M
| $168K | ﹤0.01% |
101,266
-1,600
| -2% | -$1.27K |
|
|
ELP
3082
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $167K | ﹤0.01% |
+25,000
| New | +$180K |
|
3083
Forafric Global
AFRI
$289M
| $167K | ﹤0.01% |
15,654
-2,046
| -12% | -$21.8K |
|
3084
ESS Tech
GWH
$22M
| $166K | ﹤0.01% |
13,547
-25,013
| -65% | -$282K |
|
|
CKPT
3085
DELISTED
Checkpoint Therapeutics
CKPT
| $166K | ﹤0.01% |
77,200
-194,017
| -72% | -$345K |
|
3086
Gyre Therapeutics
GYRE
$641M
| $166K | ﹤0.01% |
+13,900
| New | +$191K |
|
|
ZSTK
3087
ZeroStack Corp
ZSTK
$3.69M
| $163K | ﹤0.01% |
4,092
+2,102
| +106% | +$120K |
|
3088
Sera Prognostics
SERA
$79.9M
| $162K | ﹤0.01% |
+27,400
| New | +$245K |
|
|
MCHB
3089
Mechanics Bancorp
MCHB
$3.72B
| $160K | ﹤0.01% |
14,000
-33,100
| -70% | -$363K |
|
3090
Smartbird Inc
BIRD
$19.5M
| $159K | ﹤0.01% |
15,880
-4,485
| -22% | -$54.7K |
|
3091
ReWalk Robotics
LFWD
$20.3M
| $158K | ﹤0.01% |
3,292
-1,377
| -29% | -$79.1K |
|
3092
Vince Holding Corp
VNCE
$81.3M
| $158K | ﹤0.01% |
114,450
-1,600
| -1% | -$3.27K |
|
3093
Definitive Healthcare
DH
$72M
| $158K | ﹤0.01% |
28,900
+9,700
| +51% | +$61.1K |
|
3094
Magyar Bancorp
MGYR
$124M
| $157K | ﹤0.01% |
14,000
-2,900
| -17% | -$32.1K |
|
3095
The Oncology Institute
TOI
$486M
| $156K | ﹤0.01% |
339,400
+199,300
| +142% | +$170K |
|
|
AXG
3096
Solowin Holdings
AXG
$575M
| $155K | ﹤0.01% |
+41,300
| New | +$425K |
|
3097
Maris-Tech
MTEK
$11.4M
| $155K | ﹤0.01% |
104,900
-8,700
| -8% | -$12.4K |
|
3098
Yunhong Green CTI Ltd
YHGJ
$7.54M
| $155K | ﹤0.01% |
12,397
-1,421
| -10% | -$19K |
|
|
EMKR
3099
DELISTED
Emcore Corp
EMKR
| $155K | ﹤0.01% |
131,258
+35,308
| +37% | +$65.1K |
|
3100
Trevi Therapeutics
TRVI
$2.59B
| $155K | ﹤0.01% |
51,900
-64,942
| -56% | -$180K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.